Biogen
BIIB
NASDAQ
IPO1991
about BIIB
Biogen is a biotechnology company specializing in the development of innovative pharmaceutical treatments for various medical conditions, with a focus on neurology and immunology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $185.99 | $188.00 | $181.46 | $26.6B | 1.09M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$3.18 | n/a | n/a | 21.99% | 18.40% | 0% |